EDGAR Filing Documents for 0001395064-23-000050

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001395064-23-000050

Filing Date

2023-05-30

Accepted

2023-05-30 06:20:51

Documents

Period of Report

2023-05-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	form6k-4_053023.htm	6-K	156455
2	GRAPHIC	fy22-ceo_pay.jpg	GRAPHIC	23162
3	GRAPHIC	fy22-sti.jpg	GRAPHIC	79315
4	GRAPHIC	fy22-total_rewards.jpg	GRAPHIC	169707
5	GRAPHIC	fy22-tsr.jpg	GRAPHIC	47028
	Complete submission text file	0001395064-23-000050.txt		575898

Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668

Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111

TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 23971327
SIC: 2834 Pharmaceutical Preparations